Psychiatric medication management for Miami — residential-level optimization, 65 minutes away.

For Miami-area adults whose depression, bipolar disorder, PTSD, or anxiety has outrun outpatient medication trials, RECO Immersive's Delray Beach campus sits 65 minutes north up I-95 — close enough for weekly family involvement, far enough to separate the medication trial from Brickell's social triggers. The residential setting adds what outpatient psychiatry structurally cannot: observed adherence, correctly-timed lithium and valproate troughs, side-effect capture at onset rather than at discontinuation, and coordination with concurrent rTMS or esketamine at the affiliated RECO Health clinic. Clients leave with a documented, transferable medication plan, not a theoretical regimen.

From Brickell, Coral Gables, or Coconut Grove, the drive up I-95 to RECO Immersive’s Delray Beach campus runs about 65 minutes on a normal weekday. Close enough that Miami families stay involved through weekly programming; far enough that the geographic separation from Miami’s nightlife, high-pressure workplaces, and long-standing social triggers becomes part of the clinical mechanism itself. For adults whose depression, anxiety, PTSD, or bipolar disorder has not responded to outpatient medication trials, that distance also allows what outpatient psychiatry structurally cannot deliver: observed adherence, weekly bloodwork, and a psychiatrist who watches the response signal in real time rather than reconstructing it from a 20-minute follow-up appointment three weeks later.

RECO Immersive’s psychiatric medication management runs inside the residential program — not a weekly appointment scheduled around groups, but a continuous clinical presence with visit-anchored measurement, side-effect surveillance, and the ability to titrate on response data. That is where the residential setting adds pharmacologic value outpatient treatment cannot match: speed and precision of optimization.

What observed adherence and daily monitoring actually change

In outpatient psychiatry, whether a client actually takes sertraline at breakfast or aripiprazole at bedtime is inferred from self-report and pill counts. In residential care, adherence is observed by nursing at each administration. For medications with narrow therapeutic windows — lithium, valproate, lamotrigine during titration, clozapine — that observation is not incidental; it is what makes accurate serum-level interpretation possible in the first place. A lithium level drawn on a client who took the last dose 14 hours ago instead of 12 does not tell you what the regimen is doing.

The same structure changes how side effects are handled. Akathisia from a recent aripiprazole increase, sedation from quetiapine, tremor from lithium, or sexual side effects from an SSRI do not wait two weeks for the next appointment. They surface at the next morning’s clinical huddle and get addressed the same day — dose reduction, timing change, adjunct (propranolol for tremor, buspirone for SSRI-related dysfunction), or cross-taper to a different agent. Outpatient trials often stop working because the client silently discontinues at side-effect onset; residential care intercepts that decision before it happens.

Comprehensive lab monitoring during the residential stay

Every admission begins with a baseline lab panel: CBC, comprehensive metabolic panel, TSH, B12 and folate, vitamin D, fasting lipids, HbA1c, urine drug screen, and urine pregnancy where indicated. For clients arriving on complex regimens, the panel is expanded — prolactin on antipsychotics, ammonia on valproate where clinically warranted, EKG where cardiovascular risk or QTc-prolonging agents drive the decision.

Ongoing monitoring is medication-driven rather than schedule-driven. Lithium levels are drawn weekly during titration and at steady state, timed as true 12-hour troughs; valproate levels follow the same cadence. Metabolic panels bookend the stay for anyone on olanzapine, quetiapine, or clozapine. When labs shift a decision — a rising TSH on lithium, a triglyceride jump on olanzapine, an HbA1c that changes the risk calculus — the regimen changes with the data rather than at the next available outpatient slot.

Coordination with concurrent interventional treatment

Many residents at RECO Immersive are running a concurrent course of rTMS (a standard depression protocol of 3,000 pulses per session at 120% of motor threshold) or intranasal esketamine at the affiliated RECO Health outpatient clinic. The medication plan is coordinated with the interventional plan by the same psychiatry team, not negotiated across two independent prescribers.

That coordination has specific implications. Benzodiazepines and high-dose anticonvulsants attenuate TMS response and are tapered or paused where clinically appropriate before or during the acute course. Around esketamine sessions, monoamine oxidase inhibitors are contraindicated and stimulant timing is adjusted. When the interventional treatment produces a response — a PHQ-9 that drops from 22 to 9 across an rTMS course — the oral regimen is rebalanced to hold that gain, not left frozen at the pre-response dose.

What to expect during the psychiatric evaluation

The first psychiatric evaluation at Immersive typically runs 60 to 90 minutes and is scheduled within the first 48 hours of admission. It covers full psychiatric history, prior medication trials with response and side-effect detail, family psychiatric history, and current symptom severity anchored to standardized instruments — PHQ-9 for depression, GAD-7 for anxiety, YBOCS where OCD features are present, ASRS where ADHD is on the differential, MDQ for bipolar screening.

Substance use is assessed against the ASAM Criteria dimensions, and CIWA or COWS scoring drives any medically supervised withdrawal management, including buprenorphine induction for opioid use disorder and naltrexone initiation once opioid-free. Where trauma is the driving diagnosis, the psychiatric plan is coordinated with EMDR and trauma-focused CBT clinicians on the therapy side; where personality-disorder features complicate the picture, DBT skills programming is integrated. Motivational interviewing and ACT frame the psychoeducation around the medication plan itself, so the client leaves understanding the regimen rather than merely complying with it.

The medication plan the client leaves with

Discharge from Immersive is not the end of pharmacology; it is a handoff. Every client leaves with a written medication plan that names the current regimen, the rationale for each agent, the response data that justified the last change, the monitoring schedule for the next 90 days, and explicit next-step contingencies — what to do if PHQ-9 stalls above 10, what to do if sleep collapses, what to do if a lithium level drifts out of range.

That plan transfers cleanly to the RECO Health outpatient team in Delray Beach or, for Miami-based clients returning to a home-community prescriber in Brickell, Aventura, or Pinecrest, to whichever psychiatrist takes the ongoing case. The client leaves knowing why they are on what they are on, what to watch for, and what the next visit will focus on. That handoff clarity is what allows the pharmacologic gains from a residential stay to hold once the client is back in an outpatient rhythm.

Insurance and admissions from Miami

RECO Immersive is in-network or works with most major commercial carriers used by Miami-area members, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Admissions handles verification of benefits — residential and detox levels of care, expected patient responsibility, authorization requirements — before an admission date is set, so families are not making a clinical decision without the financial picture in front of them.

Most Miami admissions arrive by private car up I-95; RECO can arrange ground transport from Miami International Airport (MIA) or Fort Lauderdale-Hollywood (FLL) for clients flying in from further afield. The intake team coordinates the timing of the last outpatient medication dose with the admission window so nothing falls out of sync at the transition — no missed lithium dose, no abrupt SSRI discontinuation, no benzodiazepine gap that produces avoidable withdrawal on arrival.

Serving residents of: Brickell, Coral Gables, Coconut Grove, Aventura, Pinecrest.